Nitrate/nitrate derivatives vs placeboMigraine frequency Number of attacks · primary Raynaud's phenomenon1 finding from 1 reviewVasodilators for primary Raynaud's phenomenon 2021 · Cochrane Headline outcomes onlyno estimate extracted2 studies · 86 participantsVery low
Nitrate/nitrate derivatives vs placeboSeverity of attacks · primary Raynaud's phenomenon1 finding from 1 reviewVasodilators for primary Raynaud's phenomenon 2021 · Cochrane Headline outcomes onlyno estimate extracted1 study · 17 participantsVery low
Nitrate/nitrate derivatives vs placeboDuration of attacks · primary Raynaud's phenomenon1 finding from 1 reviewVasodilators for primary Raynaud's phenomenon 2021 · Cochrane Headline outcomes onlyno estimate extracted2 studies · 77 participantsGRADE not reported
Nitrate/nitrate derivatives vs placeboQoL · primary Raynaud's phenomenonThe review found no eligible studies for this question.1 finding from 1 reviewVasodilators for primary Raynaud's phenomenon 2021 · Cochrane Headline outcomes onlyno estimate extractedStudies not reportedNo studies found
Nitrate/nitrate derivatives vs placeboAdverse events (3 weeks' · primary Raynaud's phenomenon1 finding from 1 reviewVasodilators for primary Raynaud's phenomenon 2021 · Cochrane Headline outcomes onlyno estimate extracted1 study · 8 participantsGRADE not reported
Nitrate/nitrate derivatives vs placeboRCS · primary Raynaud's phenomenon1 finding from 1 reviewVasodilators for primary Raynaud's phenomenon 2021 · Cochrane Headline outcomes onlyno estimate extracted1 study · 69 participantsLow